Chemoresistance to anticancer medicines substantially reduces success in epithelial ovarian carcinoma (EOC). and medical outcome. as Chloroxine an illness progression-associated gene that’s associated with EOC recurrence and poor success [7]. Furthermore COL11A1 can be preferentially raised in cisplatin-resistant ovarian tumor cells [12 13 Nevertheless the mechanisms where COL11A1 raises chemoresistance are badly understood. With this… Continue reading Chemoresistance to anticancer medicines substantially reduces success in epithelial ovarian carcinoma